Logo image of CLA.PA

CLARANOVA SE (CLA.PA) Stock Fundamental Analysis

EPA:CLA - FR0013426004 - Common Stock

1.604 EUR
-0.02 (-0.99%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, CLA scores 3 out of 10 in our fundamental rating. CLA was compared to 108 industry peers in the Software industry. There are concerns on the financial health of CLA while its profitability can be described as average. CLA has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CLA has reported negative net income.
CLA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
Each year in the past 5 years CLA had a positive operating cash flow.
CLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

CLA has a Return On Assets of -1.14%. This is comparable to the rest of the industry: CLA outperforms 41.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLA is above the industry average of 12.57%.
The last Return On Invested Capital (%ROIC%%) for CLA is well below the 3 year average (17.26%), which needs to be investigated, but indicates that CLA had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.14%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
CLA.PA Yearly ROA, ROE, ROICCLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

With a Operating Margin value of 8.86%, CLA perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
In the last couple of years the Operating Margin of CLA has grown nicely.
CLA has a Gross Margin of 29.19%. This is in the lower half of the industry: CLA underperforms 79.63% of its industry peers.
CLA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.86%
PM (TTM) N/A
GM 29.19%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
CLA.PA Yearly Profit, Operating, Gross MarginsCLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLA is creating value.
The number of shares outstanding for CLA has been increased compared to 1 year ago.
Compared to 5 years ago, CLA has more shares outstanding
CLA has a better debt/assets ratio than last year.
CLA.PA Yearly Shares OutstandingCLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLA.PA Yearly Total Debt VS Total AssetsCLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.60, we must say that CLA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.60, CLA is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
CLA has a debt to FCF ratio of 5.38. This is a neutral value as CLA would need 5.38 years to pay back of all of its debts.
The Debt to FCF ratio of CLA (5.38) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.38
Altman-Z 0.6
ROIC/WACCN/A
WACC7.56%
CLA.PA Yearly LT Debt VS Equity VS FCFCLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.50 indicates that CLA may have some problems paying its short term obligations.
The Current ratio of CLA (0.50) is worse than 86.11% of its industry peers.
A Quick Ratio of 0.45 indicates that CLA may have some problems paying its short term obligations.
CLA has a Quick ratio of 0.45. This is amonst the worse of the industry: CLA underperforms 87.04% of its industry peers.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.45
CLA.PA Yearly Current Assets VS Current LiabilitesCLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

CLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.81%, which is quite impressive.
CLA shows a decrease in Revenue. In the last year, the revenue decreased by -0.95%.
CLA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.58% yearly.
EPS 1Y (TTM)34.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.85%
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%-2.36%

3.2 Future

CLA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.54% yearly.
Based on estimates for the next years, CLA will show a very negative growth in Revenue. The Revenue will decrease by -11.76% on average per year.
EPS Next Y84.24%
EPS Next 2Y59.54%
EPS Next 3Y43.54%
EPS Next 5YN/A
Revenue Next Year-39.33%
Revenue Next 2Y-19.45%
Revenue Next 3Y-11.76%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLA.PA Yearly Revenue VS EstimatesCLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CLA.PA Yearly EPS VS EstimatesCLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 4.54, the valuation of CLA can be described as very cheap.
Based on the Price/Forward Earnings ratio, CLA is valued cheaply inside the industry as 97.22% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, CLA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.54
CLA.PA Price Earnings VS Forward Price EarningsCLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLA indicates a rather cheap valuation: CLA is cheaper than 98.15% of the companies listed in the same industry.
99.07% of the companies in the same industry are more expensive than CLA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.05
EV/EBITDA 2.82
CLA.PA Per share dataCLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLA's earnings are expected to grow with 43.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.54%
EPS Next 3Y43.54%

More info and screens

0

5. Dividend

5.1 Amount

CLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLARANOVA SE

EPA:CLA (9/5/2025, 7:00:00 PM)

1.604

-0.02 (-0.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13
Earnings (Next)10-29 2025-10-29/amc
Inst Owners4.7%
Inst Owner ChangeN/A
Ins Owners5.02%
Ins Owner ChangeN/A
Market Cap91.76M
Analysts80
Price Target3.52 (119.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.57%
EPS NY rev (3m)-2.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.96%
Revenue NY rev (3m)-38.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.54
P/S 0.19
P/FCF 3.05
P/OCF 2.49
P/B N/A
P/tB N/A
EV/EBITDA 2.82
EPS(TTM)-0.08
EYN/A
EPS(NY)0.35
Fwd EY22.04%
FCF(TTM)0.53
FCFY32.8%
OCF(TTM)0.64
OCFY40.21%
SpS8.54
BVpS-0.3
TBVpS-2.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.14%
ROE N/A
ROCE -2165%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 8.86%
PM (TTM) N/A
GM 29.19%
FCFM 6.16%
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
ROICexc(3y)46.34%
ROICexc(5y)36.95%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.49%
ROCE(5y)18.83%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y3.39%
ROICexc growth 5Y10.18%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
F-Score7
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.38
Debt/EBITDA 0.21
Cap/Depr 55.74%
Cap/Sales 1.39%
Interest Coverage 250
Cash Conversion 66.49%
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.45
Altman-Z 0.6
F-Score7
WACC7.56%
ROIC/WACCN/A
Cap/Depr(3y)51.75%
Cap/Depr(5y)41.72%
Cap/Sales(3y)1.22%
Cap/Sales(5y)0.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.85%
EPS Next Y84.24%
EPS Next 2Y59.54%
EPS Next 3Y43.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%-2.36%
Revenue Next Year-39.33%
Revenue Next 2Y-19.45%
Revenue Next 3Y-11.76%
Revenue Next 5YN/A
EBIT growth 1Y22.32%
EBIT growth 3Y16.65%
EBIT growth 5Y26.75%
EBIT Next Year25.23%
EBIT Next 3Y14.42%
EBIT Next 5YN/A
FCF growth 1Y323.94%
FCF growth 3Y32.3%
FCF growth 5Y48.99%
OCF growth 1Y212.71%
OCF growth 3Y28.52%
OCF growth 5Y40.7%